Atherogenic Effects of Anabolic Steroids on Serum Lipid Levels
Author:
- Gary GlazerGGGary Glazer
- 1 October 1991
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 151 (10) , 1925-1933
Abstract
This article reviews the current body of literature linking anabolic steroids to atherogenic alterations in serum lipid levels. Anabolic steroids cause marked high-density lipoprotein level depression (weighted average, 52%) and severe depression of high-density lipoproteinb levels (weighted average, 78%) while raising low-density lipoprotein levels an average of 36%. The mechanism of these lipid changes, their time course in relation to anabolic steroid use, and their dependency on route of anabolic steroid administration are discussed. Interpretation of the observed lipid level changes in light of the epidemiologic data linking lipids to coronary heart disease risk is used to estimate the lipid-based increase in coronary heart disease risk due to anabolic steroid use. (Arch Intern Med. 1991;151:1925-1933)Keywords
This publication has 43 references indexed in Scilit:
- Dietary influences on cardiovascular disease risk in anabolic steroid-using and nonusing bodybuilders.Journal of the American College of Nutrition, 1989
- Anabolic Steroid Dependence with Opioid-Type FeaturesNew England Journal of Medicine, 1988
- Hepatic tumours induced by anabolic steroids in an athlete.Journal of Clinical Pathology, 1988
- Lipoprotein analysis in bodybuildersInternational Journal of Cardiology, 1987
- Androgenic-anabolic steroid effects on serum thyroid, pituitary and steroid hormones in athletesThe American Journal of Sports Medicine, 1987
- ADENOCARCINOMA OF PROSTATE IN 40-YEAR-OLD BODY-BUILDERThe Lancet, 1986
- Overview of the association between insulin and atherosclerosisMetabolism, 1985
- Nonpharmacologic and pharmacologic alteration of high-density lipoprotein cholesterol: Therapeutic approaches to prevention of atherosclerosisAmerican Heart Journal, 1985
- Reduced High-Density Lipoprotein-Cholesterol in Power Athletes: Use of Male Sex Hormone Derivates, an Atherogenic FactorInternational Journal of Sports Medicine, 1984
- Reduction of lecithin-cholesterol acyltransferase, apolipoprotein D and the Lp(a) lipoprotein with the anabolic steroid stanozololBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1984